Food and Drug Administration (FDA) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Fake Ozempic Is Surging
When Andy Morling heard about a revolutionary new weight-loss cure on the BBC last spring, he figured it might spark a shadier market for fakes. His hunch was right. Almost a year later, the law-enforcement veteran who spent the last four decades helping to bring down drug gangs and child sexual abusers is leading the charge against criminals looking to profit from the very human desire to slim down. Both organized crime and unscrupulous lone entrepreneurs are looking to capitalize on the weight-loss frenzy with concoctions that range from useless to potentially deadly. Their packaging mimics Novo Nordisk...
Source: TIME: Health - March 13, 2024 Category: Consumer Health News Authors: Ashleigh Furlong/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news

Drug Development for the Treatment of Congenital Cytomegalovirus Infection and Neonatal Enterovirus Infection - 05/07/2024
The Food and Drug Administration is holding a public, two-day workshop entitled Development of Drugs for the Treatment of Congenital Cytomegalovirus (CMV) Infection and Neonatal Enterovirus Infection. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 13, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Mirum Pharmaceuticals ’ Livmarli Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
FOSTER CITY, Calif.--(BUSINESS WIRE) March 13, 2024 -- Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved Livmarli® (maralixibat) oral solution for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 13, 2024 Category: Drugs & Pharmacology Source Type: news

FDA Roundup: March 12, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Nanox highlights study results
Nano-X Imaging (Nanox) and its deep learning medical imaging analytics subsidiary Nanox AI are touting early findings from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study. The study uses the Nanox.AI software HealthVCF to review routine CT scans and has identified up to six times more patients with vertebral compression fracture than the national average at National Health Services (NHS) hospitals in the U.K., Nanox highlighted. The company also said that the Nanox.AI algorithm has identified over 2,400 patients with vertebral compression fracture from routine CT scans that were not known to the NHS ...
Source: AuntMinnie.com Headlines - March 12, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Japan's Shionogi eyes early 2025 for U.S. release of COVID pill
OSAKA -- Japanese drugmaker Shionogi expects to be able to sell its Xocova COVID-19 treatment in the U.S. in early 2025, part of a focus on overseas sales as public funding for coronavirus medications in Japan ends this month. If the review by the U.S. Food and Drug Administration goes smoothly…#osaka #shionogi #xocovacovid19 #isaoteshirogi (Source: Reuters: Health)
Source: Reuters: Health - March 12, 2024 Category: Consumer Health News Source Type: news

FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Notice from the Food and Drug Administration (FDA) announcing the revocation of one Emergency Use Authorization (EUA) issued to Eli Lilly and Co. (Lilly) for bamlanivimab and etesevimab administered together. The revocation is effective December 14, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - March 11, 2024 Category: Rural Health Source Type: news

Cheese Recalled In 15 States Over Listeria Concerns
The Food and Drug Administration is urging food service customers in 15 states to throw out or return bags of shredded cotija, parmesan, Swiss, white cheddar and other cheeses distributed by Sargento over concerns of a potential listeria contamination, which the company says is limited to…#sargento #quesadilla #taco #italian #whitecheddar #montereyjack #asiagocheese #arizona #florida #georgia (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news

Cancer-causing chemical found in popular acne treatments, lab says
An independent laboratory is petitioning the Food and Drug Administration to pull several acne products from shelves after it says tests found dangerously high levels of benzene, a carcinogen known to cause cancer. Valisure found in its tests that benzene can form in treatments that contain…#fda #esteelaudersclinique #clearasiltargetsupup #walmart #bpo #reckitt (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news

Aromatherapy use and safety: What to know about essential oils during pregnancy
People often have questions about using essential oils before, during and after pregnancy. These natural oils are distilled from plants or other sources and retain their characteristic fragrance. Aromatherapy is the therapeutic use of essential oils, but research on its effectiveness is limited. Some studies have shown that aromatherapy may relieve anxiety and depression. The Food and Drug Administration (FDA) doesn't regulate essential oils used for aromatherapy, but they have been shown to be safe when… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 10, 2024 Category: Databases & Libraries Source Type: news

Indian Grocery Product Under FDA Radar in US
We are M9 , use this new URL M9.news for latest updates. The US Food and Drug Administration is looking into cinnamon products that might have lead in them. This isn’t just about cinnamon applesauce – it’s about ground cinnamon too. One brand that’s…#fda #urlm9news #patelbrothers #indians #ecuador #lafiesta #marcum #mtci #supremetradition #elchillar (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news

FDA clears Wegovy manufacturer to market weight-loss drug for heart health
The Food and Drug Administration on Friday approved Wegovy manufacturer Novo Nordisk ' s application to add cardiovascular benefits to the weight-loss drug ' s label. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 8, 2024 Category: Consumer Health News Source Type: news

Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits. The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo. [time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
FRIDAY, March 8, 2024 -- The U.S. Food and Drug Administration has approved Wegovy (semaglutide) for the prevention of myocardial infarction, stroke, and cardiovascular death in patients with obesity or overweight. In one multinational study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2024 Category: Pharmaceuticals Source Type: news

Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Bagsværd, Denmark, 8 March 2024– Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 8, 2024 Category: Drugs & Pharmacology Source Type: news